Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)

NCT01070745 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Changes in approach to PDA therapy

Conditions

Patent Ductus Arteriosus

Interventions

DRUG: Indomethacin
DRUG: Ibuprofen

Sponsor

Shaare Zedek Medical Center